ID   GLC4/Sb30
AC   CVCL_C5RI
DR   ChEMBL-Cells; CHEMBL3833704
DR   Wikidata; Q116049079
RX   PubMed=10025956;
CC   Selected for resistance to: ChEBI; CHEBI_2761; Dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate (Antimony potassium tartrate; KAT).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
RX   PubMed=10025956; DOI=10.1016/S0014-5793(98)01716-5;
RA   Vernhet L., Courtois A., Allain N., Payen L., Anger J.-P.,
RA   Guillouzo A., Fardel O.;
RT   "Overexpression of the multidrug resistance-associated protein (MRP1)
RT   in human heavy metal-selected tumor cells.";
RL   FEBS Lett. 443:321-325(1999).
//